Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitamin B6 Complexed with 2-Amino-Pentanoic Acid is an experimental small molecule compound consisting of vitamin B6 (specifically a pyridoxamine 5'-phosphate derivative) chemically complexed with 2-amino-pentanoic acid (also known as L-norvaline). The IUPAC name for this compound is (2S)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]pentanoic acid. It has a molecular formula of C13H21N2O7P and a molecular weight of approximately 348.29 g/mol[1][3]. This compound belongs to the class of organic compounds known as pyridoxamine 5'-phosphates, which are involved in amino acid metabolism and other enzymatic processes in the body. While vitamin B6 itself acts as a coenzyme in numerous metabolic reactions, especially those related to protein and amino acid metabolism, the specific pharmacological or clinical properties conferred by its complexation with 2-amino-pentanoic acid have not been established or widely characterized in clinical literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin b6 complexed with 2-amino-pentanoic acid.